Inhibiting KRAS G12C with CD47 and immune checkpoint overcomes intrinsic resistance to combined KRAS G12C and immune checkpoint inhibitor therapy. Hirade et al.

Published: 28 July 2025| Version 1 | DOI: 10.17632/29ww4s2sp4.1
Contributor:
Hiromichi Ebi

Description

Uncropped image of the Western blots

Files

Categories

Western Blot

Licence